Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea
- PMID: 34384016
- PMCID: PMC9016293
- DOI: 10.4143/crt.2021.449
Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea
Abstract
Purpose: This study investigated the attitudes toward risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) as cancer prevention options for BRCA1/2 carriers in healthy, young, unmarried Korean women.
Materials and methods: A nationally representative sample of 600 women, aged 20-39 years, completed a questionnaire on sociodemographic variables, preference for genetic testing, and intention to undergo risk-reducing surgeries after receiving information on the cancer risk of BRCA1/2 mutations and benefits of risk-reducing surgeries.
Results: A total of 54.7% and 57.7% had the intention to undergo RRM and RRSO, respectively, on the assumption that they were BRCA1/2 carriers. Older age and no intention to undergo genetic testing were associated with a reduced likelihood of undergoing RRM (odds ratio [OR], 0.30; 95% confidence interval [CI], 0.14 to 0.61 for age 35-39 years and OR, 0.35; 95% CI, 0.20 to 0.62 for no intention for genetic testing) and RRSO (OR, 0.39; 95% CI, 0.19 to 0.79 for age 35-39 years and OR, 0.30; 95% CI, 0.17 to 0.53 for no intention for genetic testing). Women who chose to be single were likely to undergo risk-reducing surgeries (OR, 1.67; 95% CI, 1.07 to 2.60 for RRM and OR, 1.56; 95% CI, 1.00 to 2.44 for RRSO).
Conclusion: More than 50% of healthy, unmarried, young Korean women were inclined to undergo prophylactic surgeries if they were BRCA1/2 mutation carriers. Further studies on decision-making process for cancer prevention in individuals at high risk for cancer need to be conducted.
Keywords: BRCA mutation; Risk-reducing mastectomy; Risk-reducing salpingo-oophorectomy.
Conflict of interest statement
Conflict of interest relevant to this article was not reported.
Similar articles
-
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center.Breast Cancer Res Treat. 2024 Jul;206(2):261-272. doi: 10.1007/s10549-024-07283-0. Epub 2024 Apr 12. Breast Cancer Res Treat. 2024. PMID: 38605155
-
Impact of graphical display on the intention to undergo risk-reducing salpingo-oophorectomy and mastectomy in individuals positive for BRCA pathogenic variant.Sci Rep. 2024 Oct 16;14(1):24281. doi: 10.1038/s41598-024-73929-0. Sci Rep. 2024. PMID: 39414838 Free PMC article.
-
Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants.JAMA Oncol. 2021 Apr 1;7(4):585-592. doi: 10.1001/jamaoncol.2020.7995. JAMA Oncol. 2021. PMID: 33630024 Free PMC article.
-
[Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].Gan To Kagaku Ryoho. 2014 Nov;41(11):1333-9. Gan To Kagaku Ryoho. 2014. PMID: 25434434 Review. Japanese.
-
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis.Crit Rev Oncol Hematol. 2018 Dec;132:111-115. doi: 10.1016/j.critrevonc.2018.09.018. Epub 2018 Oct 3. Crit Rev Oncol Hematol. 2018. PMID: 30447915 Review.
Cited by
-
A Scoping Review of Primary Breast Cancer Risk Reduction Strategies in East and Southeast Asia.Cancers (Basel). 2025 Jan 7;17(2):168. doi: 10.3390/cancers17020168. Cancers (Basel). 2025. PMID: 39857949 Free PMC article. Review.
-
Attitude towards genetic testing for breast cancer susceptibility genes and choice of prevention strategies in Chinese women with or without breast cancer.Cancer Biol Med. 2025 Feb 4;22(1):28-32. doi: 10.20892/j.issn.2095-3941.2024.0519. Cancer Biol Med. 2025. PMID: 39907101 Free PMC article. No abstract available.
References
-
- Park B, Dowty JG, Ahn C, Win AK, Kim SW, Lee MH, et al. Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2. Breast Cancer Res Treat. 2015;152:659–65. - PubMed
-
- Mauer C, Spencer S, Dungan J, Hurley K. Exploration of male attitudes on partnerships and sexuality with female BRCA1/2 mutation carriers. J Genet Couns. 2016;25:290–7. - PubMed
-
- Smith KR, Ellington L, Chan AY, Croyle RT, Botkin JR. Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomarkers Prev. 2004;13:733–40. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous